封面
市场调查报告书
商品编码
1439965

睡眠呼吸中止症设备 - 全球市场回顾、竞争格局、市场预测 (2030)

Sleep Apnea Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球睡眠呼吸中止设备市场规模预计到2023年将达到75.3亿美元,到2030年将达到108.2亿美元,2024-2030年预测期间复合年增长率为6.26%。对睡眠呼吸中止症设备的需求主要是由睡眠呼吸中止症病例数量的增加和肥胖人口的增加所推动的。此外,在 2024 年至 2030 年的预测期内,先进创新技术的采用增加、对睡眠呼吸中止症设备认识的提高、老年人口的增加以及产品发布和批准的增加,将增加睡眠呼吸中止症设备的数量。设备市场。

睡眠呼吸中止症设备市场动态

由于多种因素,睡眠呼吸中止症设备市场的产品需求呈现正成长,其中主要因素之一是糖尿病、气喘、鼻窦炎等盛行率的增加。

糖尿病影响呼吸的中枢控制和上呼吸道神经反射,促进睡眠障碍,并可能导致慢性阻塞性睡眠障碍,导致人们感到忧郁和焦虑,并经历白天焦虑。它可能导致疲劳和嗜睡,因此您可能需要睡眠设备来帮助您获得适当的睡眠并预防忧郁和焦虑等症状。此外,根据IDF Diabetes Atlas第10版(2022年),2022年全球约5.37亿成年人(20-79岁)将患有糖尿病,到2030年糖尿病患者总数将增至6亿、4300万人、预计到2045 年将增加到7.83 亿。根据同一数据,到2022年,将有超过120万名儿童和青少年(0-19岁)患有糖尿病。因此,糖尿病族群的增加可能会增加睡眠障碍的病例,而这些患者需要睡眠呼吸中止症来维持呼吸和上呼吸道神经反射以获得更好的睡眠,这预计将带动睡眠呼吸中止症的整体市场成长。

根据Sleep Foundation 2023 年 4 月的公告,睡眠不足可能导致打鼾和阻塞性睡眠障碍,对人的生活产生经济影响。为了遏制这种经济影响,人们需要在晚上获得充足的睡眠,以便能够适当地关注白天的工作。因此,人们在晚上可能需要睡眠呼吸中止症装置。因此,失眠病例的增加将导致打鼾和阻塞性睡眠障碍的增加,最终增加预测年内对睡眠呼吸中止装置的需求。

睡眠呼吸中止症可以在任何年龄发生,但 60 岁以上的成年人更容易患上这种疾病,因为老化与影响睡眠的心理社会因素的盛行率增加有关,因此发生的风险很高。因此,老年人口的增加将增加对睡眠呼吸中止症设备的需求。例如,根据世界卫生组织(WHO)(2022)的预测,到2030年,全球六分之一的人将超过60岁。此时,60岁及以上人口比例将从2020年的10亿增加到2030年的14亿。此外,到2050年,全球60岁及以上的人口将翻倍,达到近21亿人。根据同一份文件的统计,2020年至2050年间,全球80岁及以上老年人的数量预计将增加两倍,达到4.26亿人。

此外,睡眠问题在老年人中更为常见,因为随着身体年龄的增长,肌肉会减弱,气道会塌陷,导致夜间打鼾。当舌头、上颚和喉咙肌肉放鬆,气流变窄,无法正常呼吸时,就会发生打鼾。睡眠呼吸中止症治疗装置戴在您的鼻子或嘴巴上,以增加通过喉咙的空气量,帮助您入睡而不打鼾。因此,随着人口老化的增加,预防打鼾和睡眠呼吸中止症的睡眠呼吸中止装置的需求将会增加。展望未来,老年人口的增加可能会增加预测期内对睡眠呼吸中止症设备的需求。

因此,上述因素正在推动 2024-2030 年预测期内睡眠呼吸中止症设备市场的成长。

该报告提供了全球睡眠呼吸中止症设备市场的研究和分析,包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章睡眠呼吸中止设备市场报告简介

第二章睡眠呼吸中止设备市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章睡眠呼吸中止设备市场关键因素分析

  • 睡眠呼吸中止症设备市场的驱动因素
  • 睡眠呼吸中止症设备市场的限制与挑战
  • 睡眠呼吸中止症设备市场机遇

第五章波特对睡眠呼吸中止设备市场的五力分析

第六章 COVID-19 对睡眠呼吸中止设备市场的影响分析

第七章睡眠呼吸中止设备市场现状

  • 按产品类型
    • 治疗装置
    • 诊断装置
  • 按可携性
    • 便携的
    • 非便携式
  • 按最终用户
    • 医院/诊所
    • 家庭医疗
    • 其他
  • 区域
    • 北美睡眠呼吸中止设备市场规模(2021-2030)
    • 欧洲睡眠呼吸中止设备市场规模(2021-2030)
    • 亚太地区睡眠呼吸中止设备市场规模(2021-2030)
    • 其他地区睡眠呼吸中止设备市场规模(2021-2030)

第 8 章:睡眠呼吸中止设备市场公司与产品概况

  • Koninklijke Philips N.V.
  • ResMed
  • Fisher & Paykel Healthcare Limited.
  • AMBULANC (SHENZHEN) TECH. CO. LTD
  • Beijing Aeonmed Co., Ltd.
  • BMC.
  • BPL Medical Technologies
  • Elmaslar Medikal A.S.
  • Hebei Topson Medical Technology Co., Ltd.
  • Hunan VentMed Medical Technology Co., Ltd
  • Vivos Therapeutics, Inc
  • Guangdong Pigeon Medical Apparatus Co., Ltd.
  • Nihon Kohden Corporation
  • Drive DeVilbiss International
  • Natus Medical Incorporated
  • SOMNOmedics Gmb
  • VYAIRE
  • Compumedics Limited
  • Nox Medical
  • eXciteOSA Inc.

第9章 KOL观点

第10章项目方法

第 11 章关于 DelveInsight

第十二章 免责声明与联络我们

Product Code: DIMDCL0646

Sleep Apnea Devices Market By Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, And Others] And Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), And Actigraphy Devices]), By Portability (Portable And Non Portable), By End-User (Hospital & Clinics, Home Healthcare, And Others), and by geography expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of sleep apnea and the rising geriatric population base across the globe

The global sleep apnea devices market was valued at USD 7.53 billion in 2023, growing at a CAGR of 6.26% during the forecast period from 2024 to 2030 to reach USD 10.82 billion by 2030. The demand for sleep apnea devices is primarily being boosted due to the increasing cases of sleep apnea, and the rising population with obesity. Further, the rising adoption of advanced and innovative technologies, the rising awareness about sleep apnea devices, the increasing geriatric population, and the increasing product launches and approval among others, thereby contribute to the overall growth of the sleep apnea devices market during the forecast period from 2024-2030.

Sleep Apnea Devices Market Dynamics:

The sleep apnea devices market is witnessing a positive growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of diabetes, asthma, sinusitis, and others.

Diabetes can affect the central control of respiration and upper airway neural reflexes, promoting sleep-disordered and leading to chronic obstructive sleeping disorder which can make a person feel depressed or anxious and can lead to daytime tiredness or sleepiness, thus may need a sleeping device for proper sleep and for preventing depression or anxiety-like symptoms. Further, according to IDF Diabetes Atlas Tenth Edition 2022, in 2022 approximately 537 million adults worldwide (20-79 years) were living with diabetes, and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. From the same source, more than 1.2 million children and adolescents (0-19 years) were living with diabetes, in 2022. Thus, the increasing population with diabetes may increase the number of sleep disturbances cases and these patients might need sleep apnea devices to maintain respiration & upper airway neural reflexes to get better sleep, thereby propelling the overall market growth of sleep apnea devices.

According to the sleep foundation April 2023, insufficient sleep may lead to snoring or obstructive sleep disorder and can create an economic impact on a person's life. To control this economic impact people need proper sleep at night so they can give proper attention to their work during the day. For this, people may need sleep apnea devices at the night. Thus, the increasing cases of insomnia will lead to an increased number of snoring or obstructive sleep disorder, ultimately increasing the demand for sleep apnea devices during the forecast year.

Sleep apnea can occur at any age, but adults older than 60 years are at a higher risk of developing this disease as aging is associated with the increasing prevalence of psychosocial factors which affect sleep. Thus, the increasing geriatric population will increase the demand for sleep apnea devices. For instance, as per World Health Organization (WHO) 2022, it is predicted that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030, worldwide. Moreover, by 2050, the world's population of people aged 60 years and older will double which is nearly 2.1 billion. The statistics provided by the same source stated that the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, globally.

Further, sleep disturbance is more common in older adults because as the body ages the muscles get weakened and may lead to a collapsible airway, leading to nighttime snoring. Snoring happens when the muscles in the tongue, the roof of a person's mouth, and the throat relax which constricts airflow, and a person can't get a full breath. Sleep apnea devices are either attached to the nose or mouth to increase the amount of air that can pass through the throat and help in sleep without snoring. Thus, the increasing geriatric population will increase the need for sleep apnea devices to prevent snoring and sleep apnea. Henceforth, the increasing geriatric population may increase the demand for sleep apnea devices during the forecast period.

Therefore, the above-mentioned factors are contributing to the growth of the sleep apnea devices market during the forecast period from 2024-2030.

However, the high cost of positive airway pressure (PAP) devices, complications due to implantable devices, and others may restrict the sleep apnea devices market growth.

The sleep apnea device market was slightly significantly impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits for treatment and surgical procedures. Further, the treatment of patients suffering from chronic diseases such as asthma, diabetes, cardiovascular disorders, sleeping disorder, and others was not a priority as compared to the covid-19 infection. Additionally, the restrictions in the supply chain, raw materials, and other resources halted the manufacture. However, the demand increased significantly with the availability of sleep apnea devices over e-commerce platforms. This led to an increase in the manufacturing of sleep apnea devices. Also, the sleep apnea device provided treatment to patients in a homecare setting, thereby avoiding frequent visits to healthcare professionals. Henceforth, the afore-said factors propelled the demand for sleep apnea devices during the pandemic and are estimated to grow similarly during the forecast period.

Sleep Apnea Devices Market Segment Analysis:

Sleep Apnea Devices Market by Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, and Others], Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), and Actigraphy Devices]), Portability (Portable and Non-Portable), End-User (Hospital & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the sleep apnea devices market, the positive airway pressure (PAP) device category is expected to amass significant revenue share in the year 2023.

The PAP devices improve sleep quality, lower the risk of heart attack and stroke, and reduces daytime sleepiness. The device eliminates snoring and prevents sleep apnea.

The advantages of the PAP devices over other devices include less discomfort, being non-invasive, and being portable. PAP devices are likely to be the best treatment option in the management of obstructive sleep apnea.

The rising product launches and approvals will create a positive impact on the demand for PAP devices. For instance, in 2022, ResMed launched a new therapeutic air sense 11 PAP (positive airway pressure) device for sleep apnea which provides continuous air pressure to keep the upper airway open and make breathing easy. Many such developments are taking place that includes product launches and approvals, and collaborations, that can boost the segment demand in the upcoming years.

Therefore, the advantages and applications offered by PAP devices are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall sleep apnea devices market during the forecast period.

North America is expected to dominate the overall Sleep Apnea Devices Market:

Among all the regions, North America is estimated to account for the largest share of the sleep apnea devices market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of sleep apnea and insomnia, the rising geriatric population base in the region, and the rising chronic nasal congestion, are driving the North American sleep apnea devices market and are expected to witness positive growth in the forecast period. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about sleep apnea devices will also help the market growth in this region.

As per the Centers for Disease and Prevention Control (CDC) 2022, in 2020, 14.5% of adults had trouble falling asleep most days or every day in the past 30 days in the US. A greater percentage of non-Hispanic White (21.0%) adults had trouble staying asleep most days or every day compared with non-Hispanic Black (15.4%), Hispanic (10.6%), and non-Hispanic Asian (8.7%) adults. Younger adults were less likely to have trouble staying asleep (13.8% of those aged 18-44) compared with adults aged 45-64 (21.8%). Thus, people who suffer from any sleep problem due to some other disease can lead to insomnia ultimately they may also feel depression, anxiety, daytime tiredness or sleepiness, and other symptoms which may further lead to breathing disorders and snoring while sleeping. Snoring occurs when pharyngeal muscle tone is lowered during sleep, further reducing the cross-sectional area of the pharynx and leading to increased upper airway resistance. Snoring is often associated with a sleep disorder called obstructive sleep apnea (OSA). Thus, to control this condition of snoring person need a sleep apnea device people may need sleep apnea devices, ultimately increasing the demand for sleep apnea devices and thereby propelling the overall market in the North America region.

According to the CDC 2023, in 2022, 8.0% of people in the US aged 18 and over had asthma. As per the same source, the annual number of hospital visits for asthma was 4.9 million, in 2022, in the US. Asthma causes inflammation and narrowing of the airways, which can trigger irritation and constriction of the small airways which can lead to sleep deprivation. Thus, to maintain these cases of sleep deprivation due to asthma sleep apnea devices can be used. These devices involve wearing a nasal or face mask attached to a machine that delivers continuous air pressure to keep the upper airway open and make breathing easy. Thus, by wearing this device asthma patients can take proper sleep and prevent themselves from sleep deprivation. Hence, increasing cases of asthma will lead to an increase in the demand for sleep apnea devices.

Thus, the aforementioned factors will increase the demand for sleep apnea devices, thereby driving the North American sleep apnea devices market forward during the forecast period.

Sleep Apnea Devices Market Key Players:

Some of the key market players operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

Recent Developmental Activities in the Sleep Apnea Devices Market:

In October 2022, Airway Management, announced the launch of flexTAP, a premium lab-made oral appliance, which is designed to treat patients with snoring and mild to moderate obstructive sleep apnea.

In August 2022, Vivos Therapeutics, Inc, received FDA approval for intraoral devices used for snoring and obstructive sleep apnea.

In March 2020, the FDA approved, eXciteOSA by signifier medical technologies, a neuromuscular tongue muscle stimulator for the reduction of snoring and obstructive sleep apnea.

Key Takeaways from the Sleep Apnea Devices Market Report Study

Market size analysis for current sleep apnea devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the sleep apnea devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global sleep apnea devices market.

Various opportunities are available for the other competitor in the sleep apnea devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current sleep apnea devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for sleep apnea devices market growth in the coming future?

Target Audience who can be benefited from this Sleep Apnea Devices Market Report Study

Sleep apnea devices products providers

Research organizations and consulting companies

Sleep apnea devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in sleep apnea devices

Various End-users who want to know more about the sleep apnea devices market and the latest technological developments in the sleep apnea devices market

Frequently Asked Questions for the Sleep Apnea Devices Market:

1. What is a sleep apnea device?

Sleep apnea device is one of the most common therapies for obstructive sleep apnea. It keeps airways open while sleeping so a person can receive oxygen properly. Sleep apnea devices can significantly improve sleep quality and reduce the risk of several health issues.

2. What is the market for global sleep apnea devices?

The global sleep apnea devices market was valued at USD 7.53 billion in 2023, growing at a CAGR of 6.26% during the forecast period from 2024 to 2030 to reach USD 10.82 billion by 2030.

3. What are the drivers for the global sleep apnea devices market?

The demand for sleep apnea devices is primarily being heightened by the increasing prevalence of obstructive sleep apnea disorders and the increasing chronic diseases which lead to sleep disturbance. In addition, the advancement in sleep apnea devices, the increasing device launches, and approvals among others are thereby contributing to the overall growth of the sleep apnea devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global sleep apnea devices market?

Some of the key market players operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

5. Which region has the highest share in the sleep apnea devices market?

North America is expected to dominate the overall sleep apnea devices market during the forecast period from 2024-2030. Factors such as the rising geriatric population, the rising cases of obesity, the increasing cases of insomnia, and others will propel the demand for sleep apnea devices in North America. Furthermore, increasing technological advancement, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about sleep apnea diseases also helped the market growth in this region.

Table of Contents

1. Sleep Apnea Devices Market Report Introduction

2. Sleep Apnea Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Sleep Apnea Devices Market Key Factors Analysis

  • 4.1. Sleep Apnea Devices Market Drivers
    • 4.1.1. Increasing prevalence of obstructive sleep apnea (OSA)
    • 4.1.2. Rising geriatric population, rising number of obesity, hypertension, and other risk factors across the globe
    • 4.1.3. Increasing awareness among people about sleep apnea devices such as nose clips, chin straps, and others
  • 4.2. Sleep Apnea Devices Market Restraints and Challenges
    • 4.2.1. Complications related to implantable sleep apnea devices
    • 4.2.2. High cost of Positive Airway Pressure (PAP) devices
  • 4.3. Sleep Apnea Devices Market Opportunities
    • 4.3.1. Technological advancements in sleep apnea device

5. Sleep Apnea Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. The threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Sleep Apnea Devices Market

7. Sleep Apnea Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Therapeutic Device
      • 7.1.1.1. Positive Airway Pressure (PAP)
      • 7.1.1.2. Oral Appliances
      • 7.1.1.3. Oxygen devices
      • 7.1.1.4. Others
    • 7.1.2. Diagnostic Device
      • 7.1.2.1. Pulse Oximeter
      • 7.1.2.2. Polysomnography Devices (PSG)
      • 7.1.2.3. Actigraphy Devices
  • 7.2. By Portability
    • 7.2.1. Portable
    • 7.2.2. Non Portable
  • 7.3. By End-User
    • 7.3.1. Hospital & Clinics
    • 7.3.2. Home healthcare
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.1.1. The United States Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.1.2. Canada Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.1.3. Mexico Sleep Apnea Devices Market Size in USD Million (2021-2030)
    • 7.4.2. Europe Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.1. France Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.2. Germany Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.3. United Kingdom Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.4. Italy Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.5. Spain Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.2.6. Rest of Europe Sleep Apnea Devices Market Size in USD Million (2021-2030)
    • 7.4.3. Asia-Pacific Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.1. China Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.2. Japan Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.3. India Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.4. Australia Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.5. South Korea Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Sleep Apnea Devices Market Size in USD Million (2021-2030)
    • 7.4.4. Rest of the World (RoW) Sleep Apnea Devices Market Size in USD million (2021-2030)
      • 7.4.4.1. Middle East Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.4.2. Africa Sleep Apnea Devices Market Size in USD Million (2021-2030)
      • 7.4.4.3. South America Sleep Apnea Devices Market Size in USD Million (2021-2030)

8. Sleep Apnea Devices Market Company and Product Profiles

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. ResMed
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Fisher & Paykel Healthcare Limited.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. AMBULANC (SHENZHEN) TECH. CO. LTD
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Beijing Aeonmed Co., Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. BMC.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. BPL Medical Technologies
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Elmaslar Medikal A.S.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Hebei Topson Medical Technology Co., Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Hunan VentMed Medical Technology Co., Ltd
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Vivos Therapeutics, Inc
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Guangdong Pigeon Medical Apparatus Co., Ltd.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Nihon Kohden Corporation
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Drive DeVilbiss International
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Natus Medical Incorporated
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. SOMNOmedics Gmb
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. VYAIRE
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Compumedics Limited
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Nox Medical
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. eXciteOSA Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Sleep Apnea Devices Market in Global (2021-2030)
  • Table 4: Sleep Apnea Devices Market in Global by Product Type (2021-2030)
  • Table 5: Sleep Apnea Devices Market in Global by Portability (2021-2030)
  • Table 6: Sleep Apnea Devices Market in Global by End-User (2021-2030)
  • Table 7: Sleep Apnea Devices Market in Global by Geography (2021-2030)
  • Table 8: Sleep Apnea Devices Market in North America (2021-2030)
  • Table 9: Sleep Apnea Devices Market in North America by Country (2021-2030)
  • Table 10: Sleep Apnea Devices Market in the US (2021-2030)
  • Table 11: Sleep Apnea Devices Market in Canada (2021-2030)
  • Table 12: Sleep Apnea Devices Market in Mexico (2021-2030)
  • Table 13: Sleep Apnea Devices Market in Europe (2021-2030)
  • Table 14: Sleep Apnea Devices Market in Europe by Country (2021-2030)
  • Table 15: Sleep Apnea Devices Market in France (2021-2030)
  • Table 16: Sleep Apnea Devices Market in Germany (2021-2030)
  • Table 17: Sleep Apnea Devices Market in the United Kingdom (2021-2030)
  • Table 18: Sleep Apnea Devices Market in Italy (2021-2030)
  • Table 19: Sleep Apnea Devices Market in Spain (2021-2030)
  • Table 20: Sleep Apnea Devices Market in the Rest of Europe (2021-2030)
  • Table 21: Sleep Apnea Devices Market in Asia-Pacific (2021-2030)
  • Table 22: Sleep Apnea Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Sleep Apnea Devices Market in China (2021-2030)
  • Table 24: Sleep Apnea Devices Market in Japan (2021-2030)
  • Table 25: Sleep Apnea Devices Market in India (2021-2030)
  • Table 26: Sleep Apnea Devices Market in Australia (2021-2030)
  • Table 27: Sleep Apnea Devices Market in South Korea (2021-2030)
  • Table 28: Sleep Apnea Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Sleep Apnea Devices Market in the Rest of the World (2021-2030)
  • Table 30: Sleep Apnea Devices Market in RoW by Region (2021-2030)
  • Table 31: Sleep Apnea Devices Market in the Middle East (2021-2030)
  • Table 32: Sleep Apnea Devices Market in Africa (2021-2030)
  • Table 33: Sleep Apnea Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Sleep Apnea Devices Market in Global (2021-2030)
  • Figure 4: Sleep Apnea Devices Market in Global by Product Type (2021-2030)
  • Figure 5: Sleep Apnea Devices Market in Global by Portability (2021-2030)
  • Figure 6: Sleep Apnea Devices Market in Global by End-User (2021-2030)
  • Figure 7: Sleep Apnea Devices Market in Global by Geography (2021-2030)
  • Figure 8: Sleep Apnea Devices Market in North America (2021-2030)
  • Figure 9: Sleep Apnea Devices Market in North America by Country (2021-2030)
  • Figure 10: Sleep Apnea Devices Market in the US (2021-2030)
  • Figure 11: Sleep Apnea Devices Market in Canada (2021-2030)
  • Figure 12: Sleep Apnea Devices Market in Mexico (2021-2030)
  • Figure 13: Sleep Apnea Devices Market in Europe (2021-2030)
  • Figure 14: Sleep Apnea Devices Market in Europe by Country (2021-2030)
  • Figure 15: Sleep Apnea Devices Market in France (2021-2030)
  • Figure 16: Sleep Apnea Devices Market in Germany (2021-2030)
  • Figure 17: Sleep Apnea Devices Market in the United Kingdom (2021-2030)
  • Figure 18: Sleep Apnea Devices Market in Italy (2021-2030)
  • Figure 19: Sleep Apnea Devices Market in Spain (2021-2030)
  • Figure 20: Sleep Apnea Devices Market in the Rest of Europe (2021-2030)
  • Figure 21: Sleep Apnea Devices Market in Asia-Pacific (2021-2030)
  • Figure 22: Sleep Apnea Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Sleep Apnea Devices Market in China (2021-2030)
  • Figure 24: Sleep Apnea Devices Market in Japan (2021-2030)
  • Figure 25: Sleep Apnea Devices Market in India (2021-2030)
  • Figure 26: Sleep Apnea Devices Market in Australia (2021-2030)
  • Figure 27: Sleep Apnea Devices Market in South Korea (2021-2030)
  • Figure 28: Sleep Apnea Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Sleep Apnea Devices Market in the Rest of the World (2021-2030)
  • Figure 30: Sleep Apnea Devices Market in RoW by Region (2021-2030)
  • Figure 31: Sleep Apnea Devices Market in the Middle East (2021-2030)
  • Figure 32: Sleep Apnea Devices Market in Africa (2021-2030)
  • Figure 33: Sleep Apnea Devices Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis